Vitro Biopharma, Inc. (VTRO)

Vitro Biopharma will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$5.00 - $6.00

Shares Offered

1,000,000

Deal Size

$5.50M

Vitro Biopharma Financials Overview

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Revenue & Profits

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Apr '22 Apr 30, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Revenue	3.07	1.31	0.65
Revenue Growth	-	102.09%	-
Gross Profit	2.5	0.96	0.43
Operating Income	-3.18	-4.12	-1.27
Net Income	-5.24	-4.76	-1.64

Cash & Debt

Fiscal Year	Current	FY 2021	FY 2020
Period Ending	Apr '22 Apr 30, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Cash & Investments	2.22	4.38	0.3
Total Debt	3.01	6.31	3.2
Net Cash (Debt)	-0.79	-1.93	-2.91
Net Cash Growth	-	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Apr '22 Apr 30, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Operating Cash Flow	-1.53	-1	-0.78
Capital Expenditures	-0.21	-0.03	-0.03
Free Cash Flow	-1.75	-1.03	-0.81
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Apr '22 Apr 30, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Gross Margin	81.52%	73.20%	66.55%
Operating Margin	-103.69%	-314.03%	-195.54%
Pretax Margin	-170.83%	-362.91%	-252.43%
Profit Margin	-170.83%	-362.91%	-252.43%
FCF Margin	-56.97%	-78.66%	-124.13%